CanSino Biologics Inc Cash Flow Quality Index

Latest as of March 2022: -4.93x

CanSino Biologics Inc cash flow quality index. CanSino Biologics Inc (CJH) has a Cash Flow Quality Index of -4.93x as of March 2022. Operating cash flow of €-598.15 Million is below net income of €121.41 Million, suggesting accrual-heavy earnings not yet converted to cash. See CanSino Biologics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-4.93x
Operating CF / Net Income

Operating Cash Flow

€-598.15 Million
EUR

Net Income

€121.41 Million
EUR

Data as of

Mar 2022
Most recent filing

Cash Flow Quality Index of CanSino Biologics Inc (2021–2025)

Cash flow quality index of CanSino Biologics Inc from 2021 to 2025. Historical Cash Flow Quality Index for CanSino Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CJH operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

CanSino Biologics Inc Cash Flow Quality Index by Year (2021–2025)

CanSino Biologics Inc cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for CanSino Biologics Inc. For the full cash flow conversion analysis, see CJH cash flow conversion.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2025 2.79x €77.86 Million €27.87 Million ▲ +160.8%
2021 1.07x €2.05 Billion €1.91 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.